SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Panchsheel Organics Ltd (PANCHSHEEL)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531726 NSE: PANCHSHEEL Pharmaceuticals & Drugs | Small Cap | Panchsheel Organics Share Price

₹124.25 3.10 (2.56%)

As on 04-Jun'26 16:59

Panchsheel Organics Ltd (PANCHSHEEL)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531726 NSE: PANCHSHEEL Pharmaceuticals & Drugs | Small Cap | Panchsheel Organics Share Price

₹124.25 3.10 (2.56%)

As on 04-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹164 Cr.
Current Price
₹124.3
52-Week Low / High
₹86 / 184
TTM EPS
₹8.2
TTM Sales
₹107 Cr.
Book Value per Share
₹106.9
P/E Ratio
15.11
Lower than its 5-year historical median
Industry PE
46.5
Price to Book (P/B)
1.16
Lower than its 5-year historical median
Price to Sales (P/S)
1.53
Lower than its 5-year historical median
EV/EBITDA
9.71
Lower than its 5-year historical median
Dividend Yield
2.37%
Profitability Efficiency
Return on Equity (ROE)
10.66%
Outperforms industry median
Return on Capital Employed (ROCE)
13.65%
Outperforms industry median
Return on Assets (ROA)
8.49%
Operating Profit Margin
16.4%
Net Profit Margin
12.87%
Gross Profit Margin
18.9%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
1.86%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
-6.68%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
-2.27%
Asset Quality
Promoter Holding
56.12%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹128 Cr.
Equity
₹13.2 Cr.
Face Value
₹10
All Time Low / High
₹0.90 / 425.55

Panchsheel Organics stock performance

Key Ratios
mw4me loader

Check Before You Invest

Valuation

Somewhat Undervalued

Price Trend

Weak
Q.1 Is Panchsheel Organics Ltd a good quality company?
Panchsheel Organics Ltd is a good quality company, based on a consistently good multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Panchsheel Organics Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Panchsheel Organics Ltd vs industry peers?
Panchsheel Organics Ltd revenue CAGR is 16.24%, compared to the industry median CAGR of 5.35%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Panchsheel Organics Ltd?
Promoters hold 56.12% of the Panchsheel Organics Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Panchsheel Organics Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 14.8% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Panchsheel Organics Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 18.5%19.7%18.2%17.8%20.3%18.6%24.6%25.6%16.9%13.7%-
Value Creation
Index
0.30.40.30.30.50.30.80.80.20.0-

Growth Parameters

Sales 40.440.142.448.250.549.569103105107107
Sales YoY Gr.--0.7%5.7%13.8%4.7%-2%39.5%49.5%2%1.9%-
Adj EPS 2.93.23.745.358.311.910.710.58.2
YoY Gr.-11.9%15.6%8.9%32.5%-7.1%67.9%43.1%-10.5%-1.8%-
BVPS (₹) 20.823.426.930.435.239.647.376.194.9101.6106.9
Adj Net
Profit
2.93.23.745.458.414.114.113.811
Cash Flow from Ops. 34.63.12.54.64.9-1.809.63.8-
Debt/CF from Ops. 1.71.51.920.90.8-2.4132.50.71.4-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales 11.5%16.2%15.8%1.9%
Adj EPS 15.5%14.4%8%-1.8%
BVPS19.3%23.6%29.1%7.1%
Share Price 14% 19.9% -11.1% -20.5%

Key Financial Parameters

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
14.614.514.714.116.313.319.219.612.710.77.9
Op. Profit
Mgn %
1416.716.414.417.117.418.619.217.916.412.6
Net Profit
Mgn %
7.188.88.410.610.112.113.613.412.910.1
Debt to
Equity
0.20.30.20.20.10.10.10.10.100
Working Cap
Days
231250285280287330292307395415146
Cash Conv.
Cycle
153165183181188189161162188196102

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales40404248504969103105107
Operating Expenses + 35333641424156838690
Manufacturing Costs232246109811
Material Costs27252732302839656868
Employee Cost 3344555678
Other Costs 2333332343
Operating Profit 67779913201918
Operating Profit Margin (%) 14.0%16.7%16.2%14.4%16.9%17.4%18.6%19.2%17.9%16.4%
Other Income + 0000000133
Exceptional Items 0000000000
Interest 1010000100
Depreciation 1111111222
Profit Before Tax 45567711191918
Tax 1222223554
Profit After Tax 3344558141414
PAT Margin (%) 7.5%8.0%8.7%8.4%10.5%10.1%12.1%13.6%13.4%12.9%
Adjusted EPS (₹)3.03.23.74.05.35.08.311.910.710.5
Dividend Payout Ratio (%)16.50%15.60%0%0%0%20%6%30.20%30.60%30.60%

Valuation of Panchsheel Organics - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 2123273035404790125134
Share Capital 55555510121313
Reserves 1618222530353778112121
Debt +4655434565
Long Term Debt3110011100
Short Term Debt2554423565
Minority Interest0000000000
Trade Payables869691217162116
Others Liabilities 446445714117
Total Liabilities 37394745535975124163162

Fixed Assets

Net Fixed Assets +787767781418
Gross Block17191011111314172431
Accumulated Depreciation10113456791113
CWIP 22222224615
Investments 0000000030
Inventories12131415151925324046
Trade Receivables15152018231933393935
Cash Equivalents 11012424224
Others Assets 1144587383944
Total Assets 37394745535975124163162

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 353255-20104
PBT 56567711191918
Adjustment 11221111-0-0
Changes in Working Capital -20-1-3-2-1-12-14-3-9
Tax Paid -1-2-2-2-2-2-2-6-6-5
Cash Flow From Investing Activity + -2-3-1-1-3-1-0-34-7-16
Capex -2-2-1-1-0-2-2-4-10-16
Net Investments 0000-211-320-4
Others -1-1-00000123
Cash Flow From Financing Activity + -1-1-2-2-1-1-13616-5
Net Proceeds from Shares 000000032250
Net Proceeds from Borrowing 00-0-0-01-0-0-0-0
Interest Paid -1-0-1-0-0-0-0-1-0-0
Dividend Paid -1-1-0-0-0-1-1-4-4-4
Others 00-1-0-0-108-5-1
Net Cash Flow -10-0013-2118-18

Financial Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)15.4314.4814.5714.0516.0813.3519.1920.5213.1410.66
ROCE (%)18.5119.6618.2117.7720.3118.624.6125.6116.8713.65
Asset Turnover Ratio1.181.080.991.051.030.881.031.030.730.66
PAT to CFO Conversion(x)11.670.750.511-0.2500.710.29
Working Capital Days
Receivable Days125.50131.30148.50142.80146.70153136.10126.10135.70126.50
Inventory Days94.90107112.50106.90108.40126.30116.50102.10124.80145.50
Payable Days88.90100.8099.6088.8094.90137.10133.909299.80101.90

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Panchsheel Organics Ltd FAQs

The current trading price of Panchsheel Organics on 04-Jun-2026 16:59 is ₹124.2.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Panchsheel Organics stood at ₹163.7 Cr

The latest P/E ratio of Panchsheel Organics as of 03-Jun-2026 is 15.11.

The latest P/B ratio of Panchsheel Organics as of 03-Jun-2026 is 1.16.

The 52-week high of Panchsheel Organics is ₹184.0 and the 52-week low is ₹86.10.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Panchsheel Organics is ₹107 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Panchsheel Organics Ltd is a good quality company.

The key valuation ratios of Panchsheel Organics Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Panchsheel Organics Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Panchsheel Organics Ltd

Panchsheel Organics, incorporated in the year 1989, is a part of the Pharmaceutical Division of the Turakhia Brothers Group. Turakhia Brothers was founded in 1975 in the Mumbai, India. The Turakhia Group, promoters of the company, are engaged in the import-export trade of pharmaceutical raw materials since the past 25 years.

Panchsheel exports bulk actives to over 60 countries mainly in Europe, South East Asia, Japan and Latin America. The company's inherent strength lies in identifying relevant bulk drugs and selling them at affordable prices across the world.

Skilled people, modern equipment and broad experience contribute to the strength of Panchsheel Organics. Skilled production teams assure flexibility, efficiency and consistent standard in drugs manufacturing.

The R & D division of Panchsheel backed with experienced, highly qualified  teams provide sophisticated innovative solutions. Skilled production teams assure flexibility, efficiency and consistent standard in chemical manufacturing.

The current practices at Panchsheel are adherence to high quality and safety standards as well as full compliance with GMP procedures. The gaseous emissions are properly controlled and waste water is treated properly so as to ensure compliance with local and international risk, minimizing damage to persons and environment.

Panchsheel has free capacity in its five production sites in all over India. This capacity is would be used by interested companies for development and custom synthesis on strictly confidential terms.

Some of the basic operations carried out by Panchsheel are:

  • Hydrolysis
  • Condensation
  • Oxidation
  • Hydrogenation
  • Friedel Crafts
  • Grignard
  • Esterification
  • Nitration

Product range of the company includes:

  • Bulk Drugs - Alendronate Sodium Trihydrate,  Isoxsuprine HCL, Alprazolam, Itraconazole Pellets 22%, Amitriptyline HCL BP/USP, Ketoconazole BP/USP, Amlodipine Besylate etc.
  • Bittering Agent
  • Novel Drug Delivery System
  • Phytochemicals & Herbal Products
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×